Nemo-like kinase is critical for p53 stabilization and function in response to DNA damage

被引:40
作者
Zhang, H-H [1 ]
Li, S-Z [1 ]
Zhang, Z-Y [1 ]
Hu, X-M [1 ]
Hou, P-N [1 ]
Gao, L. [2 ]
Du, R-L [1 ]
Zhang, X-D [1 ]
机构
[1] Wuhan Univ, Dept Cell Biol, Coll Life Sci, Wuhan 430072, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Cardiol, Inst Cardiovasc Dis,Union Hosp, Wuhan 430074, Peoples R China
基金
中国国家自然科学基金; 跨世纪优秀人才计划 国家教委《跨世纪优秀人才计划》基金;
关键词
CANCER CELLS; ACETYLATION; APOPTOSIS; VIRUS; PHOSPHORYLATION; DEGRADATION; SUPPRESSES; ANTICANCER; ACTIVATION; CASCADE;
D O I
10.1038/cdd.2014.78
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The DNA damage response (DDR) acts as a protective mechanism for maintaining cell homeostasis. Nemo-like kinase (NLK) is a serine/threonine-protein kinase that has an important role in many pathways; however, its function in the DDR has not yet been defined. In our study, NLK-deficient HCT116 cells were found to be resistant to etoposide-induced cell death. We demonstrated that NLK is required for p53 activation in response to DNA damage. Remarkably, mechanistic studies revealed that NLK interacts with p53 and stabilizes p53 by blocking MDM2-mediated p53 ubiquitination and degradation. Furthermore, NLK enhances p53 activity and affects expression downstream of p53. Interestingly, these functions of NLK are not related to its kinase activity. Consistent with these results, NLK-deficient cells have a resistance effect on DNA damage. Therefore, these findings emphasize that NLK is a novel factor in DDR mechanisms.
引用
收藏
页码:1656 / 1663
页数:8
相关论文
共 36 条
  • [1] DNA damage signalling guards against activated oncogenes and tumour progression
    Bartek, J.
    Bartkova, J.
    Lukas, J.
    [J]. ONCOGENE, 2007, 26 (56) : 7773 - 7779
  • [2] DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
    Bartkova, J
    Horejsi, Z
    Koed, K
    Krämer, A
    Tort, F
    Zieger, K
    Guldberg, P
    Sehested, M
    Nesland, JM
    Lukas, C
    Orntoft, T
    Lukas, J
    Bartek, J
    [J]. NATURE, 2005, 434 (7035) : 864 - 870
  • [3] Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation
    Brooks, CL
    Gu, W
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2003, 15 (02) : 164 - 171
  • [4] Nlk is a murine protein kinase related to Erk/MAP kinases and localized in the nucleus
    Brott, BK
    Pinsky, BA
    Erikson, RL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) : 963 - 968
  • [5] Clinical and biological significance of Nemo-like kinase expression in glioma
    Cui, Gang
    Li, Zhen
    Shao, Bai
    Zhao, Li
    Zhou, Yanfeng
    Lu, Ting
    Wang, Junxiang
    Shi, Xioayong
    Wang, Jinjin
    Zuo, Gang
    Zhu, Weiwei
    Shen, Aiguo
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2011, 18 (02) : 271 - 275
  • [6] Nemo-Like Kinase Induces Apoptosis and Inhibits Androgen Receptor Signaling in Prostate Cancer Cells
    Emami, Katayoon H.
    Brown, Lisha G.
    Pitts, Tiffany E. M.
    Sun, Xizhang
    Vessella, Robert L.
    Corey, Eva
    [J]. PROSTATE, 2009, 69 (14) : 1481 - 1492
  • [7] Etoposide: Four decades of development of a topoisomerase II inhibitor
    Hande, KR
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (10) : 1514 - 1521
  • [8] The DNA damage response: Ten years after
    Harper, J. Wade
    Elledge, Stephen J.
    [J]. MOLECULAR CELL, 2007, 28 (05) : 739 - 745
  • [9] Mdm2 promotes the rapid degradation of p53
    Haupt, Y
    Maya, R
    Kazaz, A
    Oren, M
    [J]. NATURE, 1997, 387 (6630) : 296 - 299
  • [10] SIKE is an IKKε/TBK1-associated suppressor of TLR3-and virus-triggered IRF-3 activation pathways
    Huang, J
    Liu, T
    Xu, LG
    Chen, DY
    Zhai, ZH
    Shu, HB
    [J]. EMBO JOURNAL, 2005, 24 (23) : 4018 - 4028